Supplemental Figure 1 from Racial and Ethnic Disparities in Survival among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-analysis

This is a Systematic Review study (also classified as: Meta-Analysis).

October 3, 2025Open Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

Survival rates differ significantly across racial and ethnic groups in cholangiocarcinoma patients, complicating treatment and outcomes.
Key evidence reveals that disparities persist despite improvements in treatment protocols, highlighting an urgent need for targeted interventions.
Systematic review and meta-analysis of relevant studies sourced from MEDLINE and OVID provides a comprehensive overview of survival outcomes.
Calls for urgent changes in healthcare policies to address racial and ethnic disparities within cholangiocarcinoma treatment and care.

Answers are grounded in this paper and cite their sources.

Systematic review and meta-analysis highlights racial and ethnic survival disparities among cholangiocarcinoma patients.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Shubin et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share